Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study

被引:1
|
作者
Rosenkranz, Simone H. [1 ]
Wichmand, Charlotte H. [1 ]
Smedegaard, Laerke [1 ]
Moller, Sidsel [1 ,2 ]
Bjerre, Jenny [1 ]
Schou, Morten [1 ]
Torp-Pedersen, Christian [3 ,4 ]
Philbert, Berit T. [5 ]
Larroude, Charlotte [1 ]
Melchior, Thomas M. [6 ]
Nielsen, Jens C. [7 ,8 ]
Johansen, Jens B. [9 ]
Riahi, Sam [10 ,11 ]
Holmberg, Teresa [12 ]
Gislason, Gunnar [1 ,13 ,14 ]
Ruwald, Anne-Christine [5 ,6 ]
机构
[1] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Hellerup, Denmark
[2] Emergency Med Serv Copenhagen, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark
[4] Nordsjaellands Hosp, Dept Cardiol, Hillerod, Denmark
[5] Copenhagen Univ Hosp, Rigshospitalet, Dept Cardiol, Copenhagen, Denmark
[6] Zealand Univ Hosp, Dept Cardiol, Roskilde, Denmark
[7] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[8] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[9] Odense Univ Hosp, Dept Cardiol, Odense, Denmark
[10] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[11] Aalborg Univ, Dept Clin Med, Aalborg, Denmark
[12] Danish Canc Soc, Res Ctr, Copenhagen, Denmark
[13] Danish Heart Fdn, Copenhagen, Denmark
[14] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
关键词
Implantable Cardioverter Defibrillator; Workforce affiliation; Return-to-work; Employment maintenance; Epidemiology; Risk markers; HEART-FAILURE; SICK-LEAVE; FOLLOW-UP; ICD; HEALTH; DEPRESSION; IMPACT; RISK; UNEMPLOYMENT; EMPLOYMENT;
D O I
10.1093/ehjqcco/qcad054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim There are a paucity of studies investigating workforce affiliation in connection with first-time implantable cardioverter defibrillator (ICD)-implantation. This study explored workforce affiliation and risk markers associated with not returning to work in patients with ICDs.Methods Using the nationwide Danish registers, patients with a first-time ICD-implantation between 2007 and 2017 and of working age (30-65 years) were identified. Descriptive statistic and logistic regression models were used to describe workforce affiliation and to estimate risk markers associated with not returning to work, respectively. All analyses were stratified by indication for implantation (primary and secondary prevention).Results Of the 4659 ICD-patients of working age, 3300 patients (71%) were members of the workforce (employed, on sick leave or unemployed) (primary: 1428 (43%); secondary:1872 (57%)). At baseline, 842 primary and 1477 secondary prevention ICD-patients were employed. Of those employed at baseline, 81% primary and 75% secondary prevention ICD-patients returned to work within 1 year, whereof more than 80% remained employed the following year. Among patients receiving sick leave benefits at baseline, 25% were employed after 1 year. Risk markers of not returning to work were 'younger age' in primary prevention ICD-patients, while 'female sex', left ventricular ejection fraction 'LVEF & LE;40', 'lower income', and '& GE;3 comorbidities' were risk markers in secondary prevention ICD-patients. Lower educational level was a risk marker in both patient groups.Conclusion High return-to-work proportions following ICD-implantation, with a subsequent high level of employment maintenance were found. Several significant risk markers of not returning to work were identified including 'lower educational level' that posed a risk in both patient groups.Trial registration number Capital Region of Denmark, P-2019-051. Graphical Abstract Workforce affiliation in primary and secondary prevention ICD-patients.
引用
收藏
页码:314 / 325
页数:12
相关论文
共 50 条
  • [31] Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study
    Christensen, Anne M.
    Bjerre, Jenny
    Schou, Morten
    Jons, Christian
    Vinther, Michael
    Gislason, Gunnar H.
    Johansen, Jens B.
    Nielsen, Jens C.
    Petersen, Helen H.
    Riahi, Sam
    Ruwald, Anne-Christine
    EUROPACE, 2019, 21 (03): : 465 - 474
  • [32] The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy
    Zecchin, M
    Di Lenarda, A
    Proclemer, A
    Faganello, G
    Facchin, D
    Petz, E
    Sinagra, G
    EUROPACE, 2004, 6 (05): : 400 - 406
  • [33] Update on primary prevention implantable cardioverter-defibrillator therapy
    Epstein A.E.
    Current Cardiology Reports, 2009, 11 (5) : 335 - 342
  • [34] THE ECONOMIC IMPACT OF THE USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN PRIMARY PREVENTION
    Madotto, F.
    Conti, S.
    Chiodini, V
    Mantovani, L. G.
    Achilli, F.
    Curnis, A.
    Landolina, M.
    Lunati, M.
    Marzegalli, M.
    Proclemer, A.
    Fornari, C.
    Cesana, G.
    VALUE IN HEALTH, 2015, 18 (07) : A337 - A337
  • [35] Incidence of Implantable Cardioverter Defibrillator Therapy and Mortality in Primary and Secondary Prevention of Sudden Cardiac Death
    Konstantino, Yuval
    Shafat, Tali
    Novack, Victor
    Novack, Lena
    Amit, Guy
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (12): : 760 - 763
  • [36] The comparative efficacy of implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death
    Bokhari, F
    Newman, D
    Chow, C
    Greene, M
    Edwards, J
    Dorian, P
    EUROPEAN HEART JOURNAL, 2002, 23 : 8 - 8
  • [37] Implantable Cardioverter Defibrillator and Mortality in the Elderly: A Retrospective Nationwide Study
    Okada, Sho
    Matsui, Hiroki
    Yasunaga, Hideo
    Fushimi, Kiyohide
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S190 - S190
  • [38] The prognostic value of electrocardiographic alternans in the primary prevention on patients having an implantable cardioverter defibrillator
    Iammarino, Erica
    Marcantoni, Ilaria
    Sbrollini, Agnese
    Morettini, Micaela
    Swenne, Cees A.
    Burattini, Laura
    2024 IEEE INTERNATIONAL SYMPOSIUM ON MEDICAL MEASUREMENTS AND APPLICATIONS, MEMEA 2024, 2024,
  • [39] Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
    Connolly, SJ
    Hallstrom, AP
    Cappato, R
    Schron, EB
    Kuck, KH
    Zipes, DP
    Greene, HL
    Boczor, S
    Domanski, M
    Follmann, D
    Gent, M
    Roberts, RS
    EUROPEAN HEART JOURNAL, 2000, 21 (24) : 2071 - 2078
  • [40] Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death among Patients With Cancer
    Zadok, Osnat Itzhaki Ben
    Agmon, Inbar Nardi
    Neiman, Victoria
    Eisen, Alon
    Golovchiner, Gregory
    Bental, Tamir
    Schamroth-Pravda, Nili
    Kadmon, Ehud
    Goldenberg, Gustavo Ruben
    Erez, Aharon
    Kornowski, Ran
    Barsheshet, Alon
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 191 : 32 - 38